Clinical Trials Browser

Phase 1/2 × Immunoglobulin Light-chain Amyloidosis × 30 days × Clear all

NCT07081646 2026-03-13

ALACRITY

Phase 1/2 Recruiting

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT06569147 2026-03-06

Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis

Phase 1/2 Recruiting

Immunoglobulin Light-chain Amyloidosis